| Year |
Citation |
Score |
| 2024 |
Dunlop E, Daly A, Mori TA, Langer-Gould A, Pereira G, Black LJ. Plasma levels of polyunsaturated fatty acids and multiple sclerosis susceptibility in a US case-control study. Multiple Sclerosis and Related Disorders. 92: 105920. PMID 39406153 DOI: 10.1016/j.msard.2024.105920 |
0.315 |
|
| 2024 |
Piehl F, Alping P, Virtanen S, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Mellergård J, Nilsson P, Olsson T, Salzer J, et al. COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab. Annals of Neurology. PMID 38923558 DOI: 10.1002/ana.27012 |
0.442 |
|
| 2024 |
Akinsanya J, Smith JB, Langer-Gould A. Traumatic brain injury, race, ethnicity and cognition in newly diagnosed persons with multiple sclerosis. Multiple Sclerosis and Related Disorders. 86: 105577. PMID 38579569 DOI: 10.1016/j.msard.2024.105577 |
0.349 |
|
| 2023 |
Langer-Gould A, Sotirchos ES, Bourdette D. Rituximab for Multiple Sclerosis. Neurology. 102: e208063. PMID 38165314 DOI: 10.1212/WNL.0000000000208063 |
0.413 |
|
| 2023 |
Langer-Gould AM, Smith JB, Gonzales EG, Piehl F, Li BH. Multiple Sclerosis, Disease-Modifying Therapies, and Infections. Neurology(R) Neuroimmunology & Neuroinflammation. 10. PMID 37813594 DOI: 10.1212/NXI.0000000000200164 |
0.372 |
|
| 2023 |
Longinetti E, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould AM, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, Olsson T, Piehl F, et al. Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 37558400 DOI: 10.1136/jnnp-2023-331784 |
0.307 |
|
| 2023 |
Haben S, Ciplea AI, Tokic M, Timmesfeld N, Thiel S, Gold R, Langer-Gould AM, Hellwig K. Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 37536925 DOI: 10.1136/jnnp-2023-331525 |
0.385 |
|
| 2023 |
Hellwig K, Tokic M, Thiel S, Hemat S, Timmesfeld N, Ciplea AI, Gold R, Langer-Gould AM. Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy. Neurology(R) Neuroimmunology & Neuroinflammation. 10. PMID 37217309 DOI: 10.1212/NXI.0000000000200110 |
0.313 |
|
| 2023 |
Hittle M, Culpepper WJ, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Topol B, LaRocca NG, Nelson LM, Wallin MT. Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region. Jama Neurology. PMID 37184850 DOI: 10.1001/jamaneurol.2023.1135 |
0.639 |
|
| 2023 |
Fink K, Gorczyca A, Alping P, Englund S, Farmand S, Langer-Gould AM, Piehl F, McKay K, Frisell T, Razaz N. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231161492. PMID 37073483 DOI: 10.1177/13524585231161492 |
0.353 |
|
| 2022 |
Englund S, Kierkegaard M, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, Olsson T, Longinetti E, et al. Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort. Multiple Sclerosis and Related Disorders. 70: 104481. PMID 36603296 DOI: 10.1016/j.msard.2022.104481 |
0.404 |
|
| 2022 |
Longinetti E, Bower H, McKay KA, Englund S, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Mellergård J, et al. COVID-19 clinical outcomes and DMT of MS patients and population-based controls. Annals of Clinical and Translational Neurology. PMID 35993445 DOI: 10.1002/acn3.51646 |
0.407 |
|
| 2022 |
Langer-Gould AM, Gonzales EG, Smith JB, Li BH, Nelson LM. Racial and Ethnic Disparities in Multiple Sclerosis Prevalence. Neurology. 98: e1818-e1827. PMID 35501161 DOI: 10.1212/WNL.0000000000200151 |
0.669 |
|
| 2022 |
Langer-Gould AM, Gonzales EG, Smith JB, Li BH, Nelson LM. Racial and Ethnic Disparities in Multiple Sclerosis Prevalence. Neurology. PMID 35483901 DOI: 10.1212/WNL.0000000000200151 |
0.673 |
|
| 2022 |
Langer-Gould A, Cheng SC, Li BH, Smith JB, Kanter MH. Decreasing Multiple Sclerosis Treatment Expenditures and Improving Quality at the Health System Level. Annals of Neurology. PMID 35285095 DOI: 10.1002/ana.26352 |
0.347 |
|
| 2021 |
Smith JB, Li BH, Gonzales EG, Langer-Gould A. Validation of algorithms for identifying outpatient infections in MS patients using electronic medical records. Multiple Sclerosis and Related Disorders. 57: 103449. PMID 34915315 DOI: 10.1016/j.msard.2021.103449 |
0.335 |
|
| 2021 |
Langer-Gould A, Cheng SC, Li BH, Kanter MH. The Multiple Sclerosis Treatment Optimization Program. Annals of Clinical and Translational Neurology. PMID 34662494 DOI: 10.1002/acn3.51472 |
0.363 |
|
| 2021 |
Langer-Gould A. Treating severe MS relapses during pregnancy. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211012206. PMID 33929268 DOI: 10.1177/13524585211012206 |
0.409 |
|
| 2021 |
Langer-Gould A, Klocke S, Beaber B, Brara SM, Debacker J, Ayeni O, Nielsen AS. Improving quality, affordability, and equity of multiple sclerosis care. Annals of Clinical and Translational Neurology. PMID 33751857 DOI: 10.1002/acn3.51326 |
0.414 |
|
| 2021 |
McFaul D, Hakopian NN, Smith JB, Nielsen AS, Langer-Gould A. Defining Benign/Burnt-Out MS and Discontinuing Disease-Modifying Therapies. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33558306 DOI: 10.1212/NXI.0000000000000960 |
0.423 |
|
| 2021 |
Black LJ, Hetherton S, Forkan M, Gonzales EG, Smith JB, Daly A, Lucas RM, Langer-Gould A. An exploratory study of diet in childhood and young adulthood and adult-onset multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520986964. PMID 33464166 DOI: 10.1177/1352458520986964 |
0.388 |
|
| 2020 |
Razaz N, Piehl F, Frisell T, Langer-Gould AM, McKay KA, Fink K. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 33087582 DOI: 10.1212/NXI.0000000000000903 |
0.369 |
|
| 2020 |
Langer-Gould A, Black LJ, Waubant E, Smith JB, Wu J, Gonzales EG, Shao X, Koebnick C, Lucas RM, Xiang A, Barcellos LF. Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility. Multiple Sclerosis (Houndmills, Basingstoke, England). 26: 1476-1485. PMID 33063621 DOI: 10.25384/Sage.C.4657781.V1 |
0.436 |
|
| 2020 |
Adams CJ, Wu SL, Shao X, Bradshaw PT, Gonzales E, Smith JB, Xiang AH, Bellesis KH, Chinn T, Bos SD, Wendel-Haga M, Olsson T, Kockum I, Langer-Gould AM, Schaefer C, et al. Pregnancy does not modify the risk of MS in genetically susceptible women. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 33037103 DOI: 10.1212/NXI.0000000000000898 |
0.392 |
|
| 2020 |
Smith JB, Hellwig K, Fink K, Lyell DJ, Piehl F, Langer-Gould A. Rituximab, MS, and pregnancy. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32358226 DOI: 10.1212/Nxi.0000000000000734 |
0.49 |
|
| 2020 |
Ciplea AI, Langer-Gould A, de Vries A, Schaap T, Thiel S, Ringelstein M, Gold R, Hellwig K. Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32327455 DOI: 10.1212/Nxi.0000000000000723 |
0.358 |
|
| 2020 |
Langer-Gould A, Smith JB, Albers KB, Xiang AH, Wu J, Kerezsi EH, McClearnen K, Gonzales EG, Leimpeter AD, Van Den Eeden SK. Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort. Neurology. PMID 32284359 DOI: 10.1212/Wnl.0000000000009374 |
0.549 |
|
| 2020 |
Amezcua L, Smith JB, Gonzales EG, Haraszti S, Langer-Gould A. Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis. Neurology. PMID 32152131 DOI: 10.1212/Wnl.0000000000009210 |
0.446 |
|
| 2020 |
Alping P, Askling J, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, et al. Cancer Risk for Fingolimod, Natalizumab, and Rituximab in MS Patients. Annals of Neurology. PMID 32056253 DOI: 10.1002/ana.25701 |
0.414 |
|
| 2019 |
Russell RD, Langer-Gould A, Gonzales EG, Smith JB, Brennan V, Pereira G, Lucas RM, Begley A, Black LJ. Obesity, dieting, and multiple sclerosis. Multiple Sclerosis and Related Disorders. 39: 101889. PMID 31838309 DOI: 10.1016/J.Msard.2019.101889 |
0.419 |
|
| 2019 |
Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, et al. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies. Jama Neurology. PMID 31589278 DOI: 10.1001/Jamaneurol.2019.3365 |
0.434 |
|
| 2019 |
Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A. Environmental and genetic risk factors for MS: an integrated review. Annals of Clinical and Translational Neurology. PMID 31392849 DOI: 10.1002/Acn3.50862 |
0.444 |
|
| 2019 |
Langer-Gould AM. Pregnancy and Family Planning in Multiple Sclerosis. Continuum (Minneapolis, Minn.). 25: 773-792. PMID 31162316 DOI: 10.1212/CON.0000000000000745 |
0.366 |
|
| 2019 |
Culpepper WJ, Marrie RA, Langer-Gould A, Wallin MT, Campbell JD, Nelson LM, Kaye WE, Wagner L, Tremlett H, Chen LH, Leung S, Evans C, Yao S, LaRocca NG. Validation of an algorithm for identifying MS cases in administrative health claims datasets. Neurology. PMID 30770432 DOI: 10.1212/Wnl.0000000000007043 |
0.643 |
|
| 2019 |
Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG, et al. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. PMID 30770430 DOI: 10.1212/Wnl.0000000000007035 |
0.654 |
|
| 2019 |
Nelson LM, Wallin MT, Marrie RA, Culpepper WJ, Langer-Gould A, Campbell J, Buka S, Tremlett H, Cutter G, Kaye W, Wagner L, Larocca NG. A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS. Neurology. PMID 30770422 DOI: 10.1212/Wnl.0000000000007044 |
0.682 |
|
| 2019 |
Alping P, Piehl F, Langer-Gould A, Frisell T. Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations. Epidemiology (Cambridge, Mass.). 30: 230-233. PMID 30721167 DOI: 10.1097/Ede.0000000000000948 |
0.509 |
|
| 2019 |
Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, ... ... Langer-Gould A, et al. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. Plos Genetics. 15: e1007808. PMID 30653506 DOI: 10.1371/Journal.Pgen.1007808 |
0.5 |
|
| 2018 |
Langer-Gould A, Lucas RM. Vitamin D deficiency is an etiological factor for MS - No. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518808469. PMID 30499745 DOI: 10.1177/1352458518808469 |
0.432 |
|
| 2018 |
Langer-Gould A, Lucas R, Xiang AH, Chen LH, Wu J, Gonzalez E, Haraszti S, Smith JB, Quach H, Barcellos LF. MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics. Nutrients. 10. PMID 29495467 DOI: 10.3390/Nu10030268 |
0.531 |
|
| 2018 |
Langer-Gould A, Lucas RM, Xiang AH, Wu J, Chen LH, Gonzales E, Haraszti S, Smith JB, Quach H, Barcellos LF. Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis. Nutrients. 10. PMID 29414925 DOI: 10.3390/Nu10020184 |
0.435 |
|
| 2017 |
Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. Neurology. PMID 28855411 DOI: 10.1212/Wnl.0000000000004412 |
0.497 |
|
| 2017 |
Langer-Gould A, Smith JB, Hellwig K, Gonzales E, Haraszti S, Koebnick C, Xiang A. Breastfeeding, ovulatory years, and risk of multiple sclerosis. Neurology. PMID 28701499 DOI: 10.1212/Wnl.0000000000004207 |
0.497 |
|
| 2017 |
Obiwuru O, Joseph S, Liu L, Palomeque A, Tarlow L, Langer-Gould AM, Amezcua L. Perceptions of Multiple Sclerosis in Hispanic Americans: Need for Targeted Messaging. International Journal of Ms Care. 19: 131-139. PMID 28603461 DOI: 10.7224/1537-2073.2015-081 |
0.377 |
|
| 2016 |
Hellwig K, Chen LH, Stancyzk FZ, Langer-Gould AM. Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility. Plos One. 11: e0149094. PMID 26950301 DOI: 10.1371/journal.pone.0149094 |
0.452 |
|
| 2016 |
Thiel S, Langer-Gould A, Rockhoff M, Haghikia A, Queisser-Wahrendorf A, Gold R, Hellwig K. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26920382 DOI: 10.1177/1352458516634872 |
0.359 |
|
| 2016 |
Langer-Gould A. Sex hormones and multiple sclerosis: another informative failure. The Lancet. Neurology. 15: 22-3. PMID 26621681 DOI: 10.1016/S1474-4422(15)00348-8 |
0.34 |
|
| 2015 |
Hellwig K, Rockhoff M, Herbstritt S, Borisow N, Haghikia A, Elias-Hamp B, Menck S, Gold R, Langer-Gould A. Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses. Jama Neurology. 72: 1132-8. PMID 26322399 DOI: 10.1001/Jamaneurol.2015.1806 |
0.556 |
|
| 2014 |
Henson LJ, Cavalier S, Langer-Gould AM. The pill times 2: what every woman with multiple sclerosis should know. Neurology. 83: 1685. PMID 25349277 DOI: 10.1212/01.wnl.0000456505.44996.b4 |
0.372 |
|
| 2014 |
Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE, Sy LS, Chao C, Hechter R, Tseng HF. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. Jama Neurology. 71: 1506-13. PMID 25329096 DOI: 10.1001/Jamaneurol.2014.2633 |
0.443 |
|
| 2014 |
Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K. Natalizumab use during the third trimester of pregnancy. Jama Neurology. 71: 891-5. PMID 24821217 DOI: 10.1001/Jamaneurol.2014.209 |
0.377 |
|
| 2014 |
Langer-Gould A, Brara SM, Beaber BE, Zhang JL. The incidence of clinically isolated syndrome in a multi-ethnic cohort. Journal of Neurology. 261: 1349-55. PMID 24777692 DOI: 10.1007/S00415-014-7349-0 |
0.45 |
|
| 2014 |
Beaber BE, Chi MD, Brara SM, Zhang JL, Langer-Gould AM. Immunomodulatory agents and risk of postpartum multiple sclerosis relapses. The Permanente Journal. 18: 9-13. PMID 24626066 DOI: 10.7812/TPP/13-090 |
0.316 |
|
| 2014 |
Langer-Gould AM. The pill times 2: what every woman with multiple sclerosis should know. Neurology. 82: 654-5. PMID 24463629 DOI: 10.1212/WNL.0000000000000155 |
0.372 |
|
| 2013 |
Langer-Gould A, Hellwig K. One can prevent post-partum MS relapses by exclusive breast feeding: yes. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1567-8. PMID 24132002 DOI: 10.1177/1352458513505161 |
0.431 |
|
| 2013 |
Amezcua L, Lerner A, Ledezma K, Conti D, Law M, Weiner L, Langer-Gould A. Spinal cord lesions and disability in Hispanics with multiple sclerosis. Journal of Neurology. 260: 2770-6. PMID 23912723 DOI: 10.1007/S00415-013-7054-4 |
0.436 |
|
| 2013 |
Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology. 80: 1734-9. PMID 23650231 DOI: 10.1212/Wnl.0B013E3182918Cc2 |
0.54 |
|
| 2013 |
Langer-Gould A, Beaber BE. Effects of pregnancy and breastfeeding on the multiple sclerosis disease course. Clinical Immunology (Orlando, Fla.). 149: 244-50. PMID 23434027 DOI: 10.1016/J.Clim.2013.01.008 |
0.523 |
|
| 2013 |
Langer-Gould A, Brara SM, Beaber BE, Koebnick C. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology. 80: 548-52. PMID 23365063 DOI: 10.1212/Wnl.0B013E31828154F3 |
0.429 |
|
| 2012 |
Amezcua L, Chung RH, Conti DV, Langer-Gould AM. Vitamin D levels in Hispanics with multiple sclerosis. Journal of Neurology. 259: 2565-70. PMID 22588255 DOI: 10.1007/S00415-012-6537-Z |
0.335 |
|
| 2012 |
Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP. Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 377-8. PMID 21828201 DOI: 10.1177/1352458511418631 |
0.355 |
|
| 2012 |
Beaber B, Chi M, Brara S, Zhang J, Langer-Gould A. Treatment with Beta-Interferons or Glatiramer Acetate and the Risk of Postpartum Multiple Sclerosis Relapses (P06.192) Neurology. 78: P06.192-P06.192. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.192 |
0.366 |
|
| 2012 |
Hellwig K, Rockhoff M, Gold R, Langer-Gould A. When Supplemental Infant Feedings Begin, Postpartum Multiple Sclerosis Relapses Return (P06.186) Neurology. 78: P06.186-P06.186. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.186 |
0.354 |
|
| 2012 |
Amezcua L, Chung R, Conti D, Langer-Gould A. Vitamin D Levels in Hispanics with Multiple Sclerosis (P05.105) Neurology. 78: P05.105-P05.105. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.105 |
0.363 |
|
| 2012 |
Amezcua L, Liu J, Lund B, Langer-Gould A, Van Den Berg D, Lerner A, Weiner L, Conti D. Marking Its Impact in Hispanics with Multiple Sclerosis (P03.057) Neurology. 78: P03.057-P03.057. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.057 |
0.436 |
|
| 2012 |
Langer-Gould A, Brara S, Beaber B, Zhang J. The Incidence of Clinically Isolated Syndrome Is Higher in African Americans and Whites Compared with Hispanics and Asians (P01.140) Neurology. 78: P01.140-P01.140. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.140 |
0.399 |
|
| 2011 |
Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children Neurology. 77: 1143-1148. PMID 21865580 DOI: 10.1212/Wnl.0B013E31822Facdd |
0.38 |
|
| 2011 |
Langer-Gould A, Huang S, Van Den Eeden SK, Gupta R, Leimpeter AD, Albers KB, Horst R, Hollis B, Steinman L, Nelson LM. Vitamin D, pregnancy, breastfeeding, and postpartum multiple sclerosis relapses. Archives of Neurology. 68: 310-3. PMID 21059988 DOI: 10.1001/Archneurol.2010.291 |
0.62 |
|
| 2010 |
Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 855-61. PMID 20463037 DOI: 10.1177/1352458510369146 |
0.667 |
|
| 2010 |
Langer-Gould A, Gupta R, Huang S, Hagan A, Atkuri K, Leimpeter AD, Albers KB, Greenwood E, Van Den Eeden SK, Steinman L, Nelson LM. Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis. Archives of Neurology. 67: 51-7. PMID 20065129 DOI: 10.1001/Archneurol.2009.304 |
0.653 |
|
| 2009 |
Langer-Gould A, Huang SM, Gupta R, Leimpeter AD, Greenwood E, Albers KB, Van Den Eeden SK, Nelson LM. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Archives of Neurology. 66: 958-63. PMID 19506118 DOI: 10.1001/Archneurol.2009.132 |
0.683 |
|
| 2009 |
Smith CH, Waubant E, Langer-Gould A. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 29: 104-6. PMID 19491632 DOI: 10.1097/Wno.0B013E3181A63606 |
0.471 |
|
| 2008 |
Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. The New England Journal of Medicine. 358: 676-88. PMID 18272891 DOI: 10.1056/Nejmoa0706383 |
0.349 |
|
| 2006 |
Langer-Gould A, Popat RA, Huang SM, Cobb K, Fontoura P, Gould MK, Nelson LM. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Archives of Neurology. 63: 1686-91. PMID 17172607 DOI: 10.1001/Archneur.63.12.1686 |
0.706 |
|
| 2006 |
Langer-Gould A, Steinman L. Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab. Current Neurology and Neuroscience Reports. 6: 253-8. PMID 16635435 DOI: 10.1007/S11910-006-0013-Z |
0.405 |
|
| 2005 |
Berger T, Deisenhammer F, Álvarez-Cermeño JC, Masjuan J, Villar LM, Kleinschmidt-DeMasters BK, Tyler KL, Langer-Gould A, Atlas SW, Pelletier D. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis [3] (multiple letters) New England Journal of Medicine. 353: 1744-1746. PMID 16236749 DOI: 10.1056/NEJMc052311 |
0.424 |
|
| 2005 |
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. The New England Journal of Medicine. 353: 375-81. PMID 15947078 DOI: 10.1056/Nejmoa051847 |
0.346 |
|
| 2004 |
Langer-Gould A, Moses HH, Murray TJ. Strategies for managing the side effects of treatments for multiple sclerosis. Neurology. 63: S35-41. PMID 15596735 DOI: 10.1212/Wnl.63.11_Suppl_5.S35 |
0.395 |
|
| 2002 |
Langer-Gould A, Garren H, Slansky A, Ruiz PJ, Steinman L. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy-related serum factor. Journal of Immunology (Baltimore, Md. : 1950). 169: 1084-91. PMID 12097417 DOI: 10.4049/Jimmunol.169.2.1084 |
0.316 |
|
| 2002 |
Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Medicine. 8: 500-8. PMID 11984595 DOI: 10.1038/Nm0502-500 |
0.44 |
|
| Show low-probability matches. |